Taragarestrant (D-0502) is an orally active estrogen receptor degrader with anticancer activity. taragarestrant exhibits anti-proliferative effects on estrogen receptor positive breast cancer cell lines. taragarestrant can be used in cancer research.
Molecular Weight:
475.38
CAS Number:
[2118899-51-5]
Formula:
C25H25Cl2FN2O2
Target:
Others|||Estrogen Receptor/ERR
T63097
* VAT and and shipping costs not included. Errors and price changes excepted